Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 5 June (HL8120), whether they will publish the information the European Commission has provided on how SecurMed’s fee model compares with other European Union National Medicines Verification Organisations.

SecurMed’s fee model is based on a template (blue print) developed by stakeholders at a European level and published by the European Medicines Verification Organisation (EMVO). We know from discussions at the Commission led European Union Expert Group meetings that the flat fee model is being used by other National Medicines Verification Organisations (NMVOs) across Europe and therefore the United Kingdom is in line with other EU countries. It is for the EMVO and NMVOs to publish further information, rather than for the Department or the Medicines and Healthcare products Regulatory Agency in their supervisory role.